GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD

According to new, autarkic probe published successful the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications trim the fig of deaths, amputations and hospitalizations among radical with benignant 2 diabetes who besides person narrowed limb arteries associated with PAD (peripheral artery disease).